Clinical trial
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
NCT02364960
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedTargeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Early Stage Breast Cancerunresolved
Neoplasm of the Breastverified · MONDO: breast neoplasm
Breast Tumorverified · MONDO: breast neoplasm
Interventions
Sponsors & collaborators
TriHealth Inc.lead sponsor
TriHealth Hatton Research Institutecollaborator
Bethesda North Hospital Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02364960 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.